Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Blue Sky Uranium Expands Drill Plan to Advance the Ivana Uranium-Vanadium Project (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News UNITY Biotechnology Inc UBX

Healthcare Biotechnology
UNITY Biotechnology, Inc. is a biotechnology company engaged in researching and developing therapeutics to slow, halt or reverse diseases of aging. The Company is focused on creating medicines to selectively eliminate or modulate senescent cells and thereby provide transformative benefit in age-related ophthalmologic and neurologic diseases. It is targeting specific biological mechanisms... see more

Recent & Breaking News (NDAQ:UBX)

UNITY Biotechnology, Inc. Reports First Quarter 2021 Financial Results and Business Updates

GlobeNewswire May 11, 2021

UNITY Biotechnology Presents UBX1325 Data Demonstrating Improvement in Retinal Vasculature and Function in Preclinical Models of Diabetic Retinopathy Eye Diseases

GlobeNewswire May 1, 2021

UNITY Biotechnology to Present Preclinical Data on Clinical Candidate Molecule UBX1325 at the Association for Research in Vision and Ophthalmology (ARVO) 2021 Annual Meeting

GlobeNewswire April 28, 2021

UNITY Biotechnology Reports Granting of New Employment Inducement Awards

GlobeNewswire April 21, 2021

UNITY Biotechnology, Inc. Reports Fourth Quarter and Full Year 2020 Financial Results and Business Updates

GlobeNewswire March 23, 2021

UNITY Biotechnology Reports Granting of New Employment Inducement Award

GlobeNewswire March 11, 2021

UNITY Biotechnology Announces Appointment of Alexander Nguyen as General Counsel

GlobeNewswire March 8, 2021

UNITY Biotechnology to Participate in Upcoming March Investor Conferences

GlobeNewswire February 26, 2021

UNITY Biotechnology Reports Granting of New Employment Inducement Awards

GlobeNewswire February 24, 2021

Study published in Cell Metabolism Reveals New Therapeutic Approach Aimed at Restoring Vascular Health and Reversing Age-Related Eye Disease

GlobeNewswire February 8, 2021

UNITY Biotechnology Reports Granting of New Employment Inducement Awards

GlobeNewswire February 3, 2021

UNITY Biotechnology Appoints Mike Sapieha, Ph.D., as Chief Scientific Advisor

GlobeNewswire February 1, 2021

UNITY Biotechnology Reports Granting of New Employment Inducement Awards

GlobeNewswire December 16, 2020

UNITY Biotechnology Announces Appointment of Clinical Development and Industry Veteran Gilmore O'Neill, M.B., to the Board of Directors

GlobeNewswire December 14, 2020

UNITY Biotechnology, Inc. Reports Third Quarter 2020 Financial Results and Clinical Program Updates

GlobeNewswire November 4, 2020

UNITY Biotechnology Announces First Patient Dosed in Phase 1 Study of UBX1325 in Diabetic Macular Edema

GlobeNewswire October 12, 2020

UNITY Biotechnology Announces Actions to Focus on Senolytic Programs in Ophthalmology and Neurology

GlobeNewswire September 15, 2020

UNITY Biotechnology to Participate in Upcoming September Investor Conferences

GlobeNewswire September 4, 2020

UNITY Biotechnology Announces Appointment of Lynne Sullivan as Chief Financial Officer

GlobeNewswire August 31, 2020

UNITY Biotechnology Announces 12-week data from UBX0101 Phase 2 Clinical Study in Patients with Painful Osteoarthritis of the Knee

GlobeNewswire August 17, 2020